Jones Financial Companies Lllp boosted its holdings in Guardant Health, Inc. (NASDAQ:GH – Free Report) by 43.5% in the 4th quarter, HoldingsChannel reports. The firm owned 2,696 shares of the ...
Arizona State Retirement System grew its holdings in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 1.1% during ...
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune ...
Guardant Health has an expanding pipeline that could significantly boost its future market potential. Check out my ...
In a report released today, Luke Sergott from Barclays maintained a Buy rating on Guardant Health (GH – Research Report), with a price target ...
CMS approves ADLT status for Guardant Health's Shield test, setting Medicare reimbursement at $1,495. The analyst sees a ...
The test will be reimbursed at the price of $1,495 for Medicare patients during the initial nine-month ADLT period starting on April 1.
Guardant Health said the CMS determination confirms that the Shield test meets the criteria for ADLT status, which is reserved for innovative products that provide novel clinical information that ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the Centers for Medicare & Medicaid ...
Guardant Health ( NASDAQ: GH) traded higher in the morning hours on Tuesday after the company announced that the U.S. Centers ...
The test will be reimbursed at the price of $1,495 for Medicare patients during the initial nine-month ADLT period starting on April 1.
Guardant Health (GH) announced the Centers for Medicare & Medicaid Services CMS has approved Advanced Diagnostic Laboratory Test ADLT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results